Your browser doesn't support javascript.
loading
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
MacMillan, E L; Tam, R; Zhao, Y; Vavasour, I M; Li, D K B; Oger, J; Freedman, M S; Kolind, S H; Traboulsee, A L.
Afiliação
  • MacMillan EL; Division of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada erin.macmillan@ubc.ca.
  • Tam R; Department of Radiology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada/UBC MS/MRI Research Group, The University of British Columbia, Vancouver, Canada.
  • Zhao Y; UBC MS/MRI Research Group, The University of British Columbia, Vancouver, Canada.
  • Vavasour IM; Department of Radiology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
  • Li DK; Department of Radiology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada/UBC MS/MRI Research Group, The University of British Columbia, Vancouver, Canada.
  • Oger J; Division of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
  • Freedman MS; Department of Neurology, Faculty of Medicine, The University of Ottawa, Canada.
  • Kolind SH; Division of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
  • Traboulsee AL; Division of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
Mult Scler ; 22(1): 112-6, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26014604

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Glutâmico / Progressão da Doença / Esclerose Múltipla Crônica Progressiva / Glutamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Glutâmico / Progressão da Doença / Esclerose Múltipla Crônica Progressiva / Glutamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article